phenyl acetate has been researched along with Neuroendocrine Tumors in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 5 (100.00) | 2.80 |
Authors | Studies |
---|---|
Calderoni, L; Castellucci, P; Fanti, S; Telo, S; Vichi, S; Zagni, F | 1 |
Cheng, Y; Ding, N; Huo, L; Zhu, W | 1 |
Capretti, G; Carrara, S; Funel, N; Giudici, S; Nappo, G; Pepe, G; Spaggiari, P; Zerbi, A | 1 |
Huo, L; Liu, R; Zhao, L; Zhu, W | 1 |
Lin, R; Lin, Z; Miao, W; Yao, S; Zhang, J | 1 |
1 review(s) available for phenyl acetate and Neuroendocrine Tumors
Article | Year |
---|---|
Alternative and New Radiopharmaceutical Agents for Lung Cancer.
Topics: Acetates; Carbon Radioisotopes; Dideoxynucleosides; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Methionine; Misonidazole; Neoplasm Staging; Neuroendocrine Tumors; Peptides; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
4 other study(ies) available for phenyl acetate and Neuroendocrine Tumors
Article | Year |
---|---|
Extensive Tumor Thrombosis of Portal Venous System Demonstrated on 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in a Patient With Well-Differentiated Neuroendocrine Tumor.
Topics: Acetates; Adult; Aged; Female; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Portal Vein; Positron Emission Tomography Computed Tomography; Thrombosis | 2020 |
Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report.
Topics: Acetates; Cystadenoma, Serous; Gallium Radioisotopes; Humans; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Peptides, Cyclic; Positron Emission Tomography Computed Tomography | 2020 |
Positive Somatostatin Receptor Expression Demonstrated on 68Ga-NODAGA-LM3 PET/CT in a Neuroendocrine Tumor Patient With Negative Immunohistochemical Staining: Conflict or Heterogeneity.
Topics: Acetates; Heterocyclic Compounds, 1-Ring; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin; Somatostatin; Staining and Labeling | 2021 |
68Ga-DOTATATE and 68Ga-NODAGA-JR11 PET/CT Images in a Patient With Gastric Neuroendocrine Tumor.
Topics: Acetates; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2021 |